TT

Turn Therapeutics Inc.

TTRX·NASDAQ

$6.42

+1.1%
HealthcareBiotechnology

Global Health Solutions, Inc., doing business as Turn Therapeutics, operates as a pharmaceuticals company that develops drugs to treat diseases of the skin, nails, and eye. The company's delivery technology penetrates the skin and nails and reduces antibiotic resistance through acute and chronic wound care products, enabling healthcare institutions to care for a variety of skin conditions, ranging from acute to chronic wounds, skin conditions, and dermatoses. Global Health Solutions, Inc. was incorporated in 2015 and is based in Westlake Village, California.

At a Glance

Live Snapshot
Market Cap$191.24M
EPS-0.2300
P/E Ratio-16.95
Earnings Date09/02/2026

No Dividend Yield Data

TTRX has not reported any dividend yield values in the available annual periods.

No Dividend Payout Ratio Data

TTRX has not reported any dividend payout ratio values in the available annual periods.

No Net Dividends Paid Data

TTRX has not reported any net dividends paid values in the available annual periods.

TT

Turn Therapeutics Inc. Dividend History

TTRX · NASDAQ
10Y CAGR +0%
Latest $0
Annual $0
Stable dividend payments
Last Period: +0%

TTRX Dividend Payment History

TTRX · NASDAQ
DeclarationEx-DatePayment DateDividendAdjustedFrequencyGrowth
No dividend payment history available
t

Turn Therapeutics Inc. Payout Ratio Analysis

TTRX · NASDAQ
Dividends Paid
0.00
2025
Net Income
-3.19M
2025
Payout Ratio
0.00%
2025

Dividend Sustainability Analysis

Payout Ratio
0.00%

Conservative payout with excellent safety margin. Company retains significant earnings for growth, acquisitions, or building cash reserves. Dividend is highly sustainable.

FCF Payout Ratio
0.0%

Negative free cash flow while paying dividends is a major red flag. Company burning cash and cannot sustain dividend without external financing.

Sustainability
At Risk

Dividend appears unsustainable based on current metrics. High probability of reduction or elimination. Proceed with caution.